120 related articles for article (PubMed ID: 36321394)
1. Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor.
Yu XH; Wu JB; Fan HY; Dai L; Xian HC; Chen BJ; Liao P; Huang MC; Pang X; Zhang M; Liang XH; Tang YL
Oral Dis; 2024 Mar; 30(2):363-375. PubMed ID: 36321394
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
3. Targeted Knockdown of Macrophage Migration Inhibitory Factor Enhances UVB Irradiation-Induced Apoptosis Via Increasing ROS Generation in Oral Squamous Cell Carcinoma.
Chen T; Chen Q; Li F; Zeng M; Wang B; Huang S; Chen S; Tao Z
Technol Cancer Res Treat; 2023; 22():15330338231163436. PubMed ID: 37272017
[No Abstract] [Full Text] [Related]
4. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
Duan Y; Huang X; Qiao B; Ma R; Li J
Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
[TBL] [Abstract][Full Text] [Related]
5. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Zeng J; Quan J; Xia X
Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
[TBL] [Abstract][Full Text] [Related]
6. Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
Sun Q; Zhang T; Xiao Q; Mei B; Zhang X
Bioengineered; 2022 Mar; 13(3):6500-6508. PubMed ID: 35220896
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Ren Y; Law S; Huang X; Lee PY; Bacher M; Srivastava G; Wong J
Ann Surg; 2005 Jul; 242(1):55-63. PubMed ID: 15973102
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
11. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract][Full Text] [Related]
12. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.
Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
[TBL] [Abstract][Full Text] [Related]
13. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
15. Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
Houri A; Mukudai Y; Abe Y; Watanabe M; Nara M; Miyamoto S; Kurihara M; Shimane T; Shirota T
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896786
[TBL] [Abstract][Full Text] [Related]
16. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
17. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
19. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation.
He S; Zhang W; Li X; Wang J; Chen X; Chen Y; Lai R
Bioengineered; 2021 Dec; 12(1):2164-2174. PubMed ID: 34098850
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma.
Zepeda-Nuño JS; Gutiérrez-Cortés E; Hernández-Bello J; Ángeles-Sánchez J; De la Cruz-Mosso U; Cruz Á; Muñoz-Valle JF
Int J Immunopathol Pharmacol; 2021; 35():20587384211038417. PubMed ID: 34416845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
